News

December 4, 2019

High Blood Levels of 2 Hormones May Be Linked to Prostate Cancer Development, Study Says

News

High blood levels of two hormones — insulin-like growth factor-I (IGF-I) and free testosterone — are associated with increased risk of prostate cancer later in life, a new study suggests. The study, ... Read more

December 4, 2019December 6, 2019

Relugolix Induces Sustained Testosterone Reduction in Advanced PC, HERO Phase 3 Trial Results Show

News

Treatment with Myovant Sciences’ relugolix induces a long-lasting reduction in testosterone to castrate levels — similar to testosterone levels after medical or chemical castration — in nearly all men with ... Read more

December 3, 2019June 17, 2020

Keytruda Shows Promise for Some with Highly Advanced Prostate Cancer in Phase 2 Trial

News

The immunotherapy Keytruda (pembrolizumab) extended for at least two years the lives of a small proportion of men with metastatic castration-resistant prostate cancer (mCRPC) who had exhausted all other treatment options, data from ... Read more

November 14, 2019November 14, 2019

Enrollment Completed for Phase 3 Trial Testing Provenge in Prostate Cancer Patients on Active Surveillance

News

Dendreon Pharmaceuticals has completed patient enrollment ahead of schedule in an ongoing Phase 3 trial assessing the safety and efficacy of its immunotherapy Provenge (sipuleucel-T) for men with early-stage prostate ... Read more

November 13, 2019

Phase 1 DRGT-45 Trial Doses First Patient With New Oral Formulation of Abiraterone Acetate

News

A Phase 1 clinical trial testing DRGT-45 — a new oral formulation of abiraterone acetate — in men with prostate cancer has dosed its first participant, the treatment’s developer, Druggability ... Read more

November 11, 2019

Men with BRCA2 Mutations Should Get Regular PSA Screening, Phase 3 Interim Data Suggest

News

Prostate-specific antigen (PSA) testing — a controversial approach to detecting prostate cancer — spotted the cancer more often, at a younger age, and in more serious forms in men older ... Read more

November 7, 2019November 11, 2019

Use of Assisted Reproduction Techniques Linked to Increased Prostate Cancer Risk, Study Suggests

News

Men who father children through assisted reproduction techniques, either in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), may be at a higher risk of developing prostate cancer, a study ... Read more

November 6, 2019

$1.8M NIH Award to Support Work into Robotic System Able to Better Detect Prostate Cancer

News

Haichong Zhang, an assistant professor at Worcester Polytechnic Institute, has been given a Director’s Early Independence Award from the National Institutes of Health (NIH) to support his work in designing a ... Read more

November 4, 2019

Veru Completes Enrollment for Zuclomiphene Citrate Trial for ADT-Induced Hot Flashes in PC

News

Veru Healthcare has completed patient enrollment for its Phase 2 clinical trial evaluating the use of zuclomiphene citrate (VERU-944) for the treatment of hot flashes in men receiving hormone therapy for ... Read more

October 31, 2019

Prostate Cancer Patients May Benefit from Routine Tumor Genetic Testing, Study Suggests

News

Implementation of routine tumor genetic testing may help identify the approximately 30% of men with metastatic castration-resistant prostate cancer (mCRPC) who may significantly benefit from targeted treatment, namely PARP inhibitors, ... Read more